{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T15:40:51Z","timestamp":1764603651550},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T00:00:00Z","timestamp":1585526400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T00:00:00Z","timestamp":1585526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s10792-020-01331-6","type":"journal-article","created":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T17:02:37Z","timestamp":1585587757000},"page":"1641-1646","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Intracameral tissue plasminogen activator in trabeculectomy: a 1-year prospective, randomized, controlled study"],"prefix":"10.1007","volume":"40","author":[{"given":"Dana","family":"Barequet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eldar","family":"Rosenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilad","family":"Rabina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabi","family":"Shemesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimon","family":"Kurtz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,30]]},"reference":[{"key":"1331_CR1","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/0002-9394(68)91288-9","volume":"66","author":"JE Cairns","year":"1968","unstructured":"Cairns JE (1968) Trabeculectomy. Preliminary report of a new method. Am J Ophthalmol 66:673\u2013679","journal-title":"Am J Ophthalmol"},{"key":"1331_CR2","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/S0161-6420(01)00873-9","volume":"108","author":"PR Lichter","year":"2001","unstructured":"Lichter PR, Musch DC, Gillespie BW et al (2001) Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery. Ophthalmology 108:1943\u20131953","journal-title":"Ophthalmology"},{"key":"1331_CR3","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S0002-9394(02)01659-8","volume":"134","author":"AGIS Investigators","year":"2002","unstructured":"Investigators AGIS (2002) The advanced glaucoma intervention study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma. Am J Ophthalmol 134:499\u2013512","journal-title":"Am J Ophthalmol"},{"key":"1331_CR4","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.ophtha.2003.09.025","volume":"111","author":"F Ederer","year":"2004","unstructured":"Ederer F, Gaasterland DA, Dally LG et al (2004) The advanced glaucoma intervention study (AGIS): 13. Comparison of treatment outcomes within race: 10-year results. Ophthalmology 111:651\u2013664. https:\/\/doi.org\/10.1016\/j.ophtha.2003.09.025","journal-title":"Ophthalmology"},{"key":"1331_CR5","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1001\/archopht.1983.01040010795021","volume":"101","author":"EM Addicks","year":"1983","unstructured":"Addicks EM, Quigley HA, Green WR, Robin AL (1983) Histologic characteristics of filtering blebs in glaucomatous eyes. Arch Ophthalmol (Chicago, Ill 1960) 101:795\u2013798","journal-title":"Arch Ophthalmol (Chicago, Ill 1960)"},{"key":"1331_CR6","first-page":"576","volume":"19","author":"HD Jampel","year":"1988","unstructured":"Jampel HD, Morrison J, Vocci M, Quigley H (1988) Identification of fibrin\/fibrinogen in glaucoma filtration surgery wounds. Ophthalmic Surg 19:576\u2013579","journal-title":"Ophthalmic Surg"},{"key":"1331_CR7","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.ophtha.2006.01.062","volume":"113","author":"H Fontana","year":"2006","unstructured":"Fontana H, Nouri-Mahdavi K, Lumba J et al (2006) Trabeculectomy with mitomycin C: outcomes and risk factors for failure in phakic open-angle glaucoma. Ophthalmology 113:930\u2013936. https:\/\/doi.org\/10.1016\/j.ophtha.2006.01.062","journal-title":"Ophthalmology"},{"key":"1331_CR8","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1046\/j.1442-9071.2001.00437.x","volume":"29","author":"RP Singh","year":"2001","unstructured":"Singh RP, Goldberg I, Mohsin M (2001) The efficacy and safety of intraoperative and\/or postoperative 5-fluorouracil in trabeculectomy and phacotrabeculectomy. Clin Exp Ophthalmol 29:296\u2013302. https:\/\/doi.org\/10.1046\/j.1442-9071.2001.00437.x","journal-title":"Clin Exp Ophthalmol"},{"key":"1331_CR9","first-page":"22","volume":"23","author":"RR Ozment","year":"1992","unstructured":"Ozment RR, Laiw ZC, Latina MA (1992) The use of tissue plasminogen activator in experimental filtration surgery. Ophthalmic Surg 23:22\u201330","journal-title":"Ophthalmic Surg"},{"key":"1331_CR10","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/ddr.430180308","volume":"18","author":"RC Tripathi","year":"1989","unstructured":"Tripathi RC, Park JK, Tripathi BJ, Ts\u2019ao C (1989) Tissue plasminogen activator synthesis by trabecular cells and its implications for fibrinolytic therapy of the eye. Drug Dev Res 18:245\u2013254. https:\/\/doi.org\/10.1002\/ddr.430180308","journal-title":"Drug Dev Res"},{"key":"1331_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/sj.eye.6702984","volume":"23","author":"T-T Wu","year":"2009","unstructured":"Wu T-T, Wang H-H (2009) Intracameral recombinant tissue plasminogen activator for the treatment of severe fibrin reaction in endophthalmitis. Eye (Lond) 23:101\u2013107. https:\/\/doi.org\/10.1038\/sj.eye.6702984","journal-title":"Eye (Lond)"},{"key":"1331_CR12","first-page":"663","volume":"20","author":"S Fourman","year":"1989","unstructured":"Fourman S, Vaid K (1989) Effects of tissue plasminogen activator on glaucoma filter blebs in rabbits. Ophthalmic Surg 20:663\u2013667","journal-title":"Ophthalmic Surg"},{"key":"1331_CR13","first-page":"376","volume":"33","author":"M Jing","year":"1997","unstructured":"Jing M, Xi S, Chen R (1997) The inhibitory effect of tissue plasminogen activator combined with 5-fluorouracil polyphase liposome on the scar formation in experimental filtration surgery. Zhonghua Yan Ke Za Zhi 33:376\u2013380","journal-title":"Zhonghua Yan Ke Za Zhi"},{"key":"1331_CR14","first-page":"718","volume":"22","author":"S Fourman","year":"1991","unstructured":"Fourman S, Wiley L (1991) Tissue plasminogen activator modifies healing of glaucoma filtering surgery in rabbits. Ophthalmic Surg 22:718\u2013723","journal-title":"Ophthalmic Surg"},{"key":"1331_CR15","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/0002-9394(88)90598-3","volume":"106","author":"JR Ortiz","year":"1988","unstructured":"Ortiz JR, Walker SD, McManus PE et al (1988) Filtering bleb thrombolysis with tissue plasminogen activator. Am J Ophthalmol 106:624\u2013625. https:\/\/doi.org\/10.1016\/0002-9394(88)90598-3","journal-title":"Am J Ophthalmol"},{"key":"1331_CR16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3928\/1542-8877-19940101-12","volume":"25","author":"JR Piltz","year":"1994","unstructured":"Piltz JR, Starita RJ (1994) The use of subconjunctivally administered tissue plasminogen activator after trabeculectomy. Ophthalmic Surg Lasers Imaging Retin 25:51\u201353","journal-title":"Ophthalmic Surg Lasers Imaging Retin"},{"key":"1331_CR17","first-page":"854","volume":"24","author":"DW Richards","year":"1993","unstructured":"Richards DW (1993) Intracameral tissue plasminogen activator to treat blocked glaucoma implants. Ophthalmic Surg 24:854\u2013855","journal-title":"Ophthalmic Surg"},{"key":"1331_CR18","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/BF00917997","volume":"16","author":"A Szymanski","year":"1992","unstructured":"Szymanski A (1992) Promotion of glaucoma filter bleb with tissue plasminogen activator after sclerectomy under a clot. Int Ophthalmol 16:387\u2013390. https:\/\/doi.org\/10.1007\/BF00917997","journal-title":"Int Ophthalmol"},{"key":"1331_CR19","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1001\/archopht.1993.01090050020014","volume":"111","author":"MMG Olivier","year":"1993","unstructured":"Olivier MMG, Kupin TH, McDermott ML, Shin DH (1993) Intracameral tissue plasminogen activator in neovascular glaucoma. Arch Ophthalmol 111:586. https:\/\/doi.org\/10.1001\/archopht.1993.01090050020014","journal-title":"Arch Ophthalmol"},{"key":"1331_CR20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1089\/jop.1995.11.227","volume":"11","author":"PF Lee","year":"1995","unstructured":"Lee PF, Myers KS, Hsieh MM et al (1995) Treatment of failing glaucoma filtering cystic blebs with tissue plasminogen activator (tPA). J Ocul Pharmacol Ther 11:227\u2013232","journal-title":"J Ocul Pharmacol Ther"},{"key":"1331_CR21","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/S0161-6420(96)30704-5","volume":"103","author":"DC Lundy","year":"1996","unstructured":"Lundy DC, Sidoti P, Winarko T et al (1996) Intracameral tissue plasminogen activator after glaucoma surgery. Indications, effectiveness, and complications. Ophthalmology 103:274\u2013282. https:\/\/doi.org\/10.1016\/S0161-6420(96)30704-5","journal-title":"Ophthalmology"},{"key":"1331_CR22","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/ICU.0b013e3283360b68","volume":"21","author":"SJ Gedde","year":"2010","unstructured":"Gedde SJ, Heuer DK, Parrish RK (2010) Review of results from the tube versus trabeculectomy study. Curr Opin Ophthalmol 21:123\u2013128. https:\/\/doi.org\/10.1097\/ICU.0b013e3283360b68","journal-title":"Curr Opin Ophthalmol"},{"key":"1331_CR23","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/ceo.12097","volume":"41","author":"LI De Fendi","year":"2013","unstructured":"De Fendi LI, Arruda GV, Scott IU, Paula JS (2013) Mitomycin C versus 5-fluorouracil as an adjunctive treatment for trabeculectomy: a meta-analysis of randomized clinical trials. Clin Exp Ophthalmol 41:798\u2013806","journal-title":"Clin Exp Ophthalmol"},{"key":"1331_CR24","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/ceo.13383","volume":"47","author":"P Grassi","year":"2019","unstructured":"Grassi P, Lim KS (2019) Intracameral tissue plasminogen activator for blood clot obstructing trabeculectomy ostium. Clin Exp Ophthalmol 47:286\u2013287","journal-title":"Clin Exp Ophthalmol"},{"key":"1331_CR25","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1001\/archopht.119.6.809","volume":"119","author":"MF Smith","year":"2001","unstructured":"Smith MF, Doyle JW (2001) Use of tissue plasminogen activator to revive blebs following intraocular surgery. Arch Ophthalmol 119:809\u2013812","journal-title":"Arch Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-020-01331-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-020-01331-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-020-01331-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:37Z","timestamp":1666224037000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-020-01331-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,30]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["1331"],"URL":"https:\/\/doi.org\/10.1007\/s10792-020-01331-6","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,30]]},"assertion":[{"value":"1 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All the procedures performed in this study were approved by the Tel Aviv Medical Center Helsinki committee (institutional review board) (IRB# 0328-12-TLV) and were in accordance with ethical standards of the 1964 Helsinki declaration and its later amendments. Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}